Experts discuss how obstetric and pediatric clinicians can coordinate to protect newborns.
|Articles|July 26, 2011
The Ultrasound Detection of Chromosomal Anomalies
Adapted from "The Ultrasound Detection of Chromosomal Anomalies
Advertisement
Adapted from "The Ultrasound Detection of Chromosomal Anomalies-A multimedia Lecture"
by Philippe Jeanty. ISBN (0-9667878-0-3) available at
Note: some of the sections contain many images and may take some time to download
Findings in the second trimester
Advertisement
Related to this article
Experts review ACOG's 2026-27 guidance and the RSV window extension for pregnant and postpartum patients.
On September 9, 2026, certolizumab pegol received FDA Breakthrough Therapy Designation for APS pregnancy; Jane E. Salmon, MD, reviews the IMPACT trial results behind it.
SUID was the largest single contributor to the Black-White infant mortality gap in 2024 and drove the biggest share of its rise since 2020.
Garima Sharma, MD, outlines validated cardiac risk scores for antenatal screening and the postpartum transitions needed to keep high-risk patients from being lost to follow-up.
Anti-CGRP antibody exposure in early pregnancy was linked to higher spontaneous abortion risk; propranolol was not.
Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.
HPV vaccination before pregnancy was linked to lower odds of preterm birth in a Swedish study of 624,713 births.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Jane E. Salmon, MD, on the IMPACT trial of certolizumab pegol for adverse pregnancy outcomes in APS
2
SUID drives widening Black-White infant mortality gap since 2020
3
Anti-CGRP antibodies associated with higher spontaneous abortion risk
4
What ACOG's 2026-27 respiratory virus guidance means in practice
5